投资策划网—规模最大、实力最强的研究报告提供商! 关于我们 联系中撰 网站地图
稳评报告
当前位置:主页 > 稳评报告 > >> China Human Vaccine Industry Report, 2012-2016
China Human Vaccine Industry Report, 2012-2016
2012-05-25 09:25共有人浏览
更多
内 容
 

 

【Table of Contents】 
1. Overview of Vaccine Industry
1.1 Definition & Classification
1.2 Industry Chain
2. China Human Vaccine Industry 
2.1 Overview
2.2 Operating Environment
2.2.1 International Market
2.2.2 Policy Environment 
2.2.3 Biopharmaceutical Market 
2.3 Status Quo
2.4 Supply & Demand
2.5 Competition Pattern
2.6 Prospect & Dynamics
2.7 Sales Channel
3. Human Vaccine Market Segments in China
3.1 Hepatitis B Vaccine
3.1.1 Supply & Demand
3.1.2 Competition Pattern
3.1.3 Market Price
3.2 Meningococcal Vaccines
3.2.1 Supply & Demand
3.2.2 Competition Pattern
3.2.3 Market Price
3.2.4 Market Forecast
3.3 Hepatitis A Vaccine
3.3.1 Supply & Demand
3.3.2 Competition Pattern
3.3.3 Market Price
3.3.4 Market Forecast
3.4 Influenza Vaccine
3.4.1 Supply & Demand
3.4.2 Competition Pattern
3.4.3 Market Price
3.5 Hib Vaccine
3.5.1 Supply & Demand
3.5.2 Competition Pattern
3.5.3 Market Price
3.5.4 Market Forecast
3.6 Rabies Vaccine
3.6.1 Supply & Demand
3.6.2 Competition Pattern
3.6.3 Market Price
3.6.4 Market Forecast
3.7 Varicella Vaccine
3.7.1 Supply & Demand
3.7.2 Competition Pattern
3.7.3 Market Price
3.8 Pneumococcal Vaccine
3.8.1 Supply & Demand
3.8.2 Competition Pattern
3.8.3 Market Price
3.9 DTP Vaccine
3.9.1 Supply & Demand
3.9.2 Competition Pattern
3.9.3 Market Dynamics & Forecast
3.10 Poliomyelitis Vaccine
3.10.1 Supply & Demand
3.10.2 Competition Pattern
4. Import and Export of Human Vaccine in China
4.1 Export
4.1.1 Export Volume & Value
4.1.2 Export Destinations
4.2 Import
4.1.1 Import Volume & Value
4.2.2 Country/Region of origin
5. Major Human Vaccine Manufacturers in China
5.1 China National Biotec Group
5.1.1 Beijing Tiantan Biological Products Co., Ltd
5.2 Hualan Biological Engineering Inc.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Client and Supplier
5.2.6 R&D and Investment
5.2.7 Vaccine Business
5.3 Chongqing Zhifei Biological Products Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Client
5.3.6 R&D and Investment
5.4 Walvax Biotechnology Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Client and Supplier
5.4.6 R&D and Investment
5.5 Sinovac Biotech Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R&D and Investment
5.6 Liaoning Chengda Co., Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Client
5.6.6 Vaccine Business
5.7 Changchun BCHT Biotechnology Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.8 Changchun Changsheng Life Sciences Limited
5.8.1 Profile
5.8.2 Operation
5.9 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.10 Shenzhen Kangtai Biological Products Co. Ltd.
5.10.1 Profile
5.10.2 Operation
5.11 Dalian Hissen Bio-Pharm Co., Ltd.
5.11.1 Profile
 
【Figures & Tables】
Classification of Vaccines
Vaccine Industry Chain
EPI Human Vaccine Varieties in China, 2011
Global Human Vaccine Market Size, 2007-2011 
Sales of Global Top 5 Human Vaccine Manufacturers, 2007-2011 
R &D of New Vaccines Worldwide, 2009-2012
Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-2011
Policies Concerning Vaccine Industry in China
Sales Value and Total Profit of Biological & Biochemical Product Industry in China, 2008- 2011
Market Size of Human Vaccine in China, 2007-2011
Major Human Vaccine Varieties and Producers in China
Gross Margin of Major Human Vaccine Manufacturers in China, 2007-2011
Lot Release Quantity and Proportion of EPI and Extra EPI Vaccines in China, 2007-2011
EPI Human Vaccine Market Share in China by Lot Release Quantity, 2007-2011
Extra EPI Human Vaccine Market Share in China by Lot Release Quantity, 2007-2011
R &D of New Human Vaccine in China by the End of Mar. 2012
Events Related to Vaccine Business of Foreign Corporations in China, 2011-2012
Vaccine Distribution Channel in China
Lot Release Quantity of Hepatitis B Vaccine in China by Dosage Form, 2007-2011 
Hepatitis B Vaccine (CHO Cell) Suppliers and Lot Release Quantity in China, 2007-2011 
Hepatitis B Vaccine (Yeast) Suppliers and Lot Release Quantity in China, 2007-2011
Market Prices of Hepatitis B Vaccine in Some Regions of China, 2012
Meningitis Morbidity and Mortality in China, 2008-2011
Lot Release Quantity of Meningococcal Vaccines in China by Type, 2007-2011 
Suppliers and Lot Release Quantity of A Meningococcal Vaccine, 2007-2011 
Suppliers and Lot Release Quantity of A+C Meningococcal Vaccine, 2007-2011
Suppliers and Lot Release Quantity of ACYW135 Meningococcal Vaccine in China, 2008-2011
Market Price of Meningococcal Vaccines in Some Regions of China, 2012 
Consumption Forecast of A-MCV, A+C-MCV and ACYW135 Meningococcal Vaccine in China, 2012-2015E 
Hepatitis A Morbidity and Mortality in China, 2008-2011
Hepatitis A Vaccine Lot Release Quantity in China, 2007-2011 
Hepatitis A Vaccine Suppliers and Lot Release Quantity in China, 2007-2011
Market Price of Hepatitis A Vaccine in China, 2012 
Consumption Forecast of Hepatitis A Vaccine in China, 2012-2015E
Influenza Morbidity and Mortality in China, 2008-2011
H1N1 Influenza Morbidity and Mortality in China, 2009-2011
Lot Release Quantity of Influenza Vaccine in China, 2007-2011 
Suppliers and Lot Release Quantity of Influenza Split Vaccine in China, 2007-2011 
Influenza Subunit Vaccine Suppliers and Lot Release Quantity in China, 2007-2011 
Market Price of Influence Vaccine in China, 2012
Hib Vaccine Lot Release Quantity in China, 2007-2011 
Hib Vaccine Suppliers and Lot Release Quantity in China, 2007-2011 
Market Price of Hib Vaccine in Some Regions of China, 2012
Sales Volume Forecast of Hib Vaccine in China, 2012-2015E
Rabies Morbidity and Mortality in China, 2007-2011
Human Rabies Vaccine Lot Release Quantity in China, 2007-2011 
Human Rabies Vaccine Lot Release Quantity in China by Type, 2007-2011 
Human Vero Cell Rabies Vaccine Suppliers and Lot Release Quantity in China, 2007-2011 
Human BHK Cell Rabies Vaccine Suppliers and Lot Release Quantity in China, 2007-2011
Market Price of Human Rabies Vaccine in Some Regions of China, 2012
Sales Volume Forecast of Human Rabies Vaccine in China, 2012-2015E
Varicella Vaccine Lot Release Quantity in China, 2007-2011
Suppliers and Lot Release Quantity of Varicella Vaccine in China, 2007-2011 
Market Price of Varicella Vaccine in Some Regions of China, 2012 
Lot Release Quantity of Pneumococcal Vaccine in China, 2007-2011
Suppliers and Lot Release Quantities of 7-valent and 23-valent Pneumococcal Vaccines in China, 2007-2011
Market Price of Pneumococcal Vaccines in Some Regions of China, 2012
DTP Vaccine Lot Release Quantity in China, 2007-2010 
DTPa Vaccine Suppliers and Lot Release Quantity in China, 2007-2011
Poliomyelitis Vaccine Lot Release Quantity in China, 2007-2011
Poliomyelitis Vaccine Suppliers and Lot Release Quantity in China, 2007-2011 
Export Volume & Value of Human Vaccine in China, 2009- 2011
Average Export Price of Human Vaccine in China, 2009- 2011
Export Destinations of Chinese Human Vaccines, 2011
Import Volume & Value of Human Vaccine in China, 2009-2011
Average Import Price of Human Vaccine in China, 2009-2011
Import Origins of Human Vaccine in China, 2011
Major Controlled Companies of Tiantan Biological and Their Revenue and Net Income 
Revenue and Total Profit of Tiantan Biological, 2007-2012
Revenue of Tiantan Biological by Product, 2007-2011
Revenue of Tiantan Biological by Region, 2007-2011
Gross Margin of Tiantan Biological by Product, 2007-2011
Tiantan Biological’s Procurement from Top 5 Suppliers and Proportion in Total Procurement, 2007-2011
Contribution of Top 5 Clients to Revenue of Tiantan Biological, 2007-2011
Top 5 Clients of Tiantan Biological and Their Contribution in Sales, 2011
Vaccine Revenue and Gross Margin of Tiantan Biological, 2007-2011
Lot Release Quantity and Proportion of Tiantan Biological’s Vaccines, 2009-2011
Revenue and Total Profit of Hualan Biological, 2007-2011
Revenue of Hualan Biological by Industry, 2007-2011
Revenue Structure of Hualan Biological by Industry, 2007-2011
Revenue of Hualan Biological by Product, 2007-2011
Revenue Structure of Hualan Biological by Product, 2007-2011
Revenue of Hualan Biological by Region, 2007-2011
Revenue Structure of Hualan Biological by Region, 2007-2011
Gross Margin of Hualan Biological by Industry, 2007-2011
Gross Margin of Hualan Biological by Product, 2007-2011
Hualan Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2007-2011
Hualan Biological’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2011
Lot Release Quantity and Proportion of Hualan Biological’s Vaccines, 2009-2011
Vaccine Revenue and Gross Margin of Hualan Biological, 2007-2011
Events Related to Vaccine Business of Hualan Biological, 2011-2012
Main Products of Zhifei Biological and Its Subsidiaries
Revenue and Profit of Zhifei Biological, 2007-2011
Revenue of Zhifei Biological by Product, 2010-2011
Lot Release Quantity and Proportion of Zhifei Biological’s Vaccines, 2011
Revenue of Zhifei Biological by Region, 2009-2011
Gross Margin of Zhifei Biological by Product, 2007-2011
Zhifei Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2007-2011
R&D Costs and % of Total Revenue of Zhifei Biological, 2008-2011
New Vaccine Development Schedule of Zhifei Biological, 2011-2013
Released Vaccines and Capacity of Walvax Biotechnology
Revenue and Profit of Walvax Biotechnology, 2007-2011
Revenue of Walvax Biotechnology by Product, 2007-2011
Lot Release Quantity and Proportion of Walvax Biotechnology’s Vaccines, 2009-2011
Revenue of Walvax Biotechnology by Region, 2010-2011
Gross Margin of Walvax Biotechnology, 2007-2011
Walvax Biological’s Revenue from Top 5 Clients and Its Procurement from Top 5 Suppliers, 2007-2011
Name List and Revenue Contribution of Walvax Biological’s Top 5 Clients, 2011
Name List and Procurement Contribution of Walvax Biological’s Top 5 Suppliers, 2011
R&D Costs and % of Total Revenue of Walvax Biological, 2009-2011
On-going New Vaccine R&D of Walvax Biological, as of Dec. 31, 2011
Revenue and Profit of Sinovac Biotech Ltd., 2007-2011
Revenue of Sinovac Biotech Ltd. by Product, 2007-2011
Lot Release Quantity and Proportion of Sinovac Biotech Ltd.’s Vaccines, 2008-2011
Gross Margin of Sinovac Biotech Ltd., 2007-2011
R&D Costs and % of Total Revenue of Sinovac Biotech Ltd., 2007-2011
Revenue and Net Income of Liaoning Chengda, 2007-2011
Revenue of Liaoning Chengda by Industry, 2007-2011
Revenue Structure of Liaoning Chengda by Industry, 2007-2011
Revenue of Liaoning Chengda by Region, 2007-2011
Revenue Structure of Liaoning Chengda by Region, 2007-2011
Gross Margin of Liaoning Chengda by Industry, 2007-2011
Liaoning Chengda’s Revenue from Top 5 Clients and % of Total Revenue, 2007-2011
Lot Release Quantity and Proportion of Chengda Biotechnology’s Vaccines, 2009-2011
Human Rabies Vaccine Sales of Liaoning Chengda, 2009-2011
Vaccine Gross Margin of Liaoning Chengda, 2009-2011
Vaccine Sales and Total Profit of Liaonig Chengda, 2009-2011
Revenue and Total Profit of Changchun BCHT, 2009-2011
Lot Release Quantity and Proportion of Changchun BCHT’s Vaccines, 2009-2011
Lot Release Quantity and Proportion of Changchun Changsheng’s Vaccines, 2008-2011
Vaccines of Zhejiang Tianyuan Bio-Pharmaceutical
Lot Release Quantity and Proportion of Zhejiang Tianyuan Bio-Pharmaceutical’s Vaccines 
2008-2011
Lot Release Quantity and Proportion of Kangtai Biological’s Vaccines, 2008-2011 
Lot Release Quantity and Proportion of Hissen Bio-pharm’s Vaccines, 2009-2011
Vaccine Projects of Hissen Bio-pharm, 2011
 

【编辑:中国投资政策网】 TOP
专项定制报告专项定制报告分类
专项报告类别:
商业计划书 | 可行性研究报告 | 资金申请报告
可行性报告 | 项目申请报告 | 英文报告
联系方式
·联系人:
余先生、方小姐
·电话号码:
15989039303、(0086)020-28908140
·地址:
广州市番禺区桥南街福德路241号奥园广场塔三1305室

订购流程订购流程
① 签订可行性报告订购合同;
② 通过银行转帐、邮局汇款等形式款项;
③ 中国投资策划网见到汇款底单或者转帐底单后,24小时内发送可行性研究报告电子版,72小时内寄送正式版以及发票。